We assist leading pharmaceutical and medical product companies in anticipating industry changes, creating innovative approaches, and developing capabilities to guarantee lasting performance and profitable growth.
McKinsey leads in biopharma consulting globally, with 3,750 projects implemented in the industry over the past five years. Our clients include the big pharmaceutical laboratories, but also biotech firms, medium-sized labs, medical product manufacturers, and generics producers. We have played a role in the development of eight of the 10 main prescription drug brands, and in eight of the industry’s 10 biggest M&A operations.
We have deep expertise in strategy, operational excellence, and organization, and apply it to areas as disparate as R&D and marketing. Drawing on our extensive experience, we can develop integrated approaches to the key challenges confronting our clients: identifying new growth opportunities, optimizing R&D investments, strengthening go-to-market strategies, extracting maximum value from new product launches in an increasingly complex environment, and adapting business models to respond to new demands from healthcare system actors.